| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.06 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |